… coronary heart disease,8 and heart failure,9 metabolic disorders like type … management plan. This multitarget therapeutic strategy could be particularly beneficial … metabolomic signatures of lipid-modifying therapies through drug target Mendelian …

… 504 people with chronic heart failure attending outpatient clinics to … iron in people with heart failure. The latest, FAIR-HF2 … of hospital admissions for heart failure and cardiovascular mortality at … given as add-on therapy for people with moderate …

… antagonists (MRAs) for patients with heart failure with reduced ejection fraction (HFrEF … patients did not receive the therapy. Older age, sex, and the …

… articles on the subject of heart failure Heart failure (HF) is a complex … to consider pathogenetic mechanism-based therapeutic strategies to improve prognosis … in transthyretin cardiac amyloidosis), device therapies, cardiac contractility modulation and …

… stymie progress for early-stage therapeutics.” The institute will license … Low Institute for Therapeutics The Low Institute for Therapeutics is a … chronic kidney disease, pulmonary fibrosis, heart failure, rheumatoid arthritis, organ transplant rejection …

… heart failure. Our work introduces an entirely new type of therapy … devastating disease.” “Preventing heart failure after a heart attack … ultimately going into heart failure.” Gianneschi is the … the heart and causes heart failure. Although current treatments …

…  in patients with end-stage heart failure. Vaxcellbio recently signed a letter … called NK (natural killer) cell therapies for a separate advanced clinical …  agreed to supply NK cell therapies for a pancreatic cancer study …

… is developing precision-engineered cell therapies for chronic inflammatory diseases. … development candidates in osteoarthritis and heart failure, and is powering partnerships … “concept to cure” advanced therapies solution. Bringing together subject matter …

… NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) were more likely to … included ischemic heart disease and heart failure. In ARASENS, serious adverse reactions … in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone …

… the UK. About Travere Therapeutics At Travere Therapeutics, we are in rare … for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology … been evaluated in patients with heart failure. If clinically significant fluid retention …